Finance

Beta
Lists
ACB:TSE
Aurora Cannabis Inc
4,22 CAD
+1,69%
(+0,070) 1D
19-июн., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for ACB...
Open
4,14 CAD
High
4,22 CAD
Low
4,14 CAD
Mkt. cap
239,31 млн
Avg. vol.
410,19 миң
Volume
98,20 миң
52-wk high
9,33 CAD
52-wk low
3,77 CAD
EPS
-0,78 CAD
Beta
0,38
Shares outstanding
61,94 млн
No. of employees
1 миң
Open
4,14 CAD
High
4,22 CAD
Low
4,14 CAD
Mkt. cap
239,31 млн
Avg. vol.
410,19 миң
Volume
98,20 миң
52-wk high
9,33 CAD
52-wk low
3,77 CAD
EPS
-0,78 CAD
Beta
0,38
Shares outstanding
61,94 млн
No. of employees
1 миң
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ACB in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACB in the last 3 months.
Highest
Current 4,22 USD
5,65 USD (+33,85%)
Average
4,59 USD (+8,77%)
Lowest
3,53 USD (-16,35%)
News stories
From sources across the web
Wealth Awesome
Wealth Awesome
·
21 саат мурун
Why Aurora Cannabis Inc stock is gaining today
Profile
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB. After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO. Wikipedia
About Aurora Cannabis Inc
CEOMiguel Martin
Employees1,03 миң
Founded2006-ж., 21-дек.
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 11-июн.
Fiscal period
Q4 2026
EPS / Est. (CAD)
- / -0,50 CAD
Revenue / Est. (CAD)
38,01 млн / 75,42 млн
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
98,02 млн
90,37 млн
94,19 млн
38,01 млн
Cost of goods sold
70,07 млн
58,08 млн
47,57 млн
8,22 млн
Cost of revenue
70,07 млн
58,08 млн
47,57 млн
8,22 млн
Research and development expenses
829,00 миң
904,00 миң
1,30 млн
986,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43,44 млн
42,11 млн
41,06 млн
41,56 млн
Operating expense
48,17 млн
50,88 млн
44,44 млн
39,82 млн
Total operating expenses
118,24 млн
108,96 млн
92,01 млн
48,04 млн
Operating income
-20,22 млн
-18,59 млн
2,18 млн
-10,03 млн
Other non operating income
584,00 миң
886,00 миң
-703,00 миң
-47,00 миң
EBT including unusual items
-19,38 млн
-46,98 млн
-1,58 млн
11,41 млн
EBT excluding unusual items
-19,38 млн
-14,55 млн
-1,58 млн
-5,05 млн
Income tax expense
-3,00 миң
6,19 млн
164,00 миң
-4,26 млн
Effective tax rate
0,02%
-13,18%
-10,39%
-37,29%
Other operating expenses
-
-
-
-
Net income
-15,21 млн
-51,47 млн
1,82 млн
-71,10 млн
Net profit margin
-15,52%
-56,96%
1,93%
-187,04%
Earnings per share
-
-
-
-
Interest and investment income
1,97 млн
1,85 млн
991,00 миң
5,33 млн
Interest expense
-1,78 млн
-2,22 млн
-2,11 млн
-
Net interest expenses
193,00 миң
-374,00 миң
-1,12 млн
5,33 млн
Depreciation and amortization charges
1,71 млн
2,90 млн
2,62 млн
-3,42 млн
EBITDA
-14,04 млн
-12,36 млн
8,58 млн
-6,60 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more